Mapping Alzheimer's disease heterogeneity with molecular imaging biomarkers.
Saved in:
| Title: | Mapping Alzheimer's disease heterogeneity with molecular imaging biomarkers. |
|---|---|
| Authors: | Harput E; Laboratory of Neuroimaging and Innovative Molecular Tracers (NIMTlab), Geneva University Neurocentre and Faculty of Medicine, University of Geneva, Geneva, Switzerland., Boccalini C; Laboratory of Neuroimaging and Innovative Molecular Tracers (NIMTlab), Geneva University Neurocentre and Faculty of Medicine, University of Geneva, Geneva, Switzerland., Mathoux G; Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospitals, Geneva, Switzerland., Prior JO; Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Lausanne, Switzerland., Testart N; Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Lausanne, Switzerland., Jreige M; Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Lausanne, Switzerland., Garibotto V; Laboratory of Neuroimaging and Innovative Molecular Tracers (NIMTlab), Geneva University Neurocentre and Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospitals, Geneva, Switzerland.; CIBM, Centre for Biomedical Imaging, University of Geneva, Geneva, Switzerland. |
| Source: | European journal of clinical investigation [Eur J Clin Invest] 2026 Jan; Vol. 56 (1), pp. e70163. Date of Electronic Publication: 2025 Dec 17. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 0245331 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2362 (Electronic) Linking ISSN: 00142972 NLM ISO Abbreviation: Eur J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
